Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron D Jachimowicz

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Acta Haematologica|September 18, 2014
The challenging aspects of managing adolescents and young adults with Hodgkin's lymphomaRon D Jachimowicz, Andreas Engert
Molecular & Cellular Oncology|May 28, 2019
UBQLN4 promotes non-homologous end joining by repressing DNA end-resectionRon D Jachimowicz, H Christian Reinhardt
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 19, 2014
Multi-specific antibodies for cancer immunotherapyRon D Jachimowicz, Sven Borchmann, Achim Rothe
Cell Cycle (Georgetown, Tex.)|May 23, 2019
DNA double-strand break repair pathway choice - from basic biology to clinical exploitationRon D Jachimowicz, Jonas Goergens, H Christian Reinhardt
Lancet (London, England)|October 18, 2025
Glofitamab with GemOx for diffuse large B-cell lymphomaPeter Borchmann, Ron D Jachimowicz, Bastian von Tresckow
Infection|April 7, 2022
Correspondence to: hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccinationRosanne Sprute, Marie-Lisa Hieber, Ron D Jachimowicz
Cells|October 17, 2020
Targeting DNA Repair, Cell Cycle, and Tumor Microenvironment in B Cell LymphomaPaul J Bröckelmann, Mathilde R W de Jong, Ron D Jachimowicz
Infection|February 26, 2022
Hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccinationMarie-Lisa Hieber, Rosanne Sprute, Dennis A Eichenauer, et al.
Cells|October 27, 2022
Genomic Amplification of <i>UBQLN4</i> Is a Prognostic and Treatment Resistance FactorYuta Kobayashi, Matias A Bustos, Yoshiaki Shoji, et al.
Scientific Reports|January 29, 2025
Publisher Correction: Starvation-induced metabolic rewiring affects mTORC1 composition in vivoEdgar Kaade, Simone Mausbach, Nina Erps, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Acta Haematologica|September 18, 2014
The challenging aspects of managing adolescents and young adults with Hodgkin's lymphomaRon D Jachimowicz, Andreas Engert
Molecular & Cellular Oncology|May 28, 2019
UBQLN4 promotes non-homologous end joining by repressing DNA end-resectionRon D Jachimowicz, H Christian Reinhardt
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 19, 2014
Multi-specific antibodies for cancer immunotherapyRon D Jachimowicz, Sven Borchmann, Achim Rothe
Cell Cycle (Georgetown, Tex.)|May 23, 2019
DNA double-strand break repair pathway choice - from basic biology to clinical exploitationRon D Jachimowicz, Jonas Goergens, H Christian Reinhardt
Lancet (London, England)|October 18, 2025
Glofitamab with GemOx for diffuse large B-cell lymphomaPeter Borchmann, Ron D Jachimowicz, Bastian von Tresckow
Infection|April 7, 2022
Correspondence to: hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccinationRosanne Sprute, Marie-Lisa Hieber, Ron D Jachimowicz
Cells|October 17, 2020
Targeting DNA Repair, Cell Cycle, and Tumor Microenvironment in B Cell LymphomaPaul J Bröckelmann, Mathilde R W de Jong, Ron D Jachimowicz
Infection|February 26, 2022
Hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccinationMarie-Lisa Hieber, Rosanne Sprute, Dennis A Eichenauer, et al.
Cells|October 27, 2022
Genomic Amplification of <i>UBQLN4</i> Is a Prognostic and Treatment Resistance FactorYuta Kobayashi, Matias A Bustos, Yoshiaki Shoji, et al.
Scientific Reports|January 29, 2025
Publisher Correction: Starvation-induced metabolic rewiring affects mTORC1 composition in vivoEdgar Kaade, Simone Mausbach, Nina Erps, et al.
Pageof 4